{
    "id": "ngn_matrixMatch_siadh_001",
    "seed": "BATCH-300-135-1771349224290",
    "itemType": "matrixMatch",
    "cjmm": "evaluateOutcomes",
    "difficulty": 4,
    "stem": "The nurse is caring for a 68-year-old male client diagnosed with small cell lung cancer who is being treated for Syndrome of Inappropriate Antidiuretic Hormone (SIADH). The client was admitted with a serum sodium of 118 mEq/L and confusion. The current treatment plan includes a 1000 mL/day fluid restriction, seizure precautions, and a continuous infusion of 3% sodium chloride via a peripheral IV. The nurse is evaluating the client's response to treatment over the past 24 hours.",
    "matrixMatchPrompt": "For each clinical finding, click to specify if the finding indicates the client's condition is **Improving**, **Unchanged**, or **Worsening**.",
    "rows": [
        {
            "id": "row_01",
            "rowItem": "Serum sodium level of 124 mEq/L"
        },
        {
            "id": "row_02",
            "rowItem": "Client is alert and oriented to person, place, and time"
        },
        {
            "id": "row_03",
            "rowItem": "Weight decrease of 1.5 kg since admission"
        },
        {
            "id": "row_04",
            "rowItem": "Client reports intense thirst"
        },
        {
            "id": "row_05",
            "rowItem": "Erythema and swelling noted at the peripheral IV site"
        },
        {
            "id": "row_06",
            "rowItem": "24-hour urine output of 1400 mL"
        }
    ],
    "columns": [
        {
            "id": "col_01",
            "columnItem": "Improving"
        },
        {
            "id": "col_02",
            "columnItem": "Unchanged"
        },
        {
            "id": "col_03",
            "columnItem": "Worsening"
        }
    ],
    "answer": [
        {
            "rowIndex": 0,
            "colIndex": 0
        },
        {
            "rowIndex": 1,
            "colIndex": 0
        },
        {
            "rowIndex": 2,
            "colIndex": 0
        },
        {
            "rowIndex": 3,
            "colIndex": 1
        },
        {
            "rowIndex": 4,
            "colIndex": 2
        },
        {
            "rowIndex": 5,
            "colIndex": 0
        }
    ],
    "answerBreakdown": {
        "rows": [
            {
                "id": "row_01",
                "rationale": "This finding indicates the client's condition is **Improving**. The primary goal in treating SIADH is to correct the hyponatremia. An increase in serum sodium from a critically low 118 mEq/L to 124 mEq/L demonstrates a positive therapeutic response to fluid restriction and hypertonic saline infusion."
            },
            {
                "id": "row_02",
                "rationale": "This finding indicates the client's condition is **Improving**. Neurological changes, such as confusion, are a primary symptom of the cerebral edema caused by severe hyponatremia. The client's return to being alert and oriented is a direct clinical indicator that serum sodium levels are rising and cerebral edema is resolving."
            },
            {
                "id": "row_03",
                "rationale": "This finding indicates the client's condition is **Improving**. SIADH leads to fluid volume excess and dilutional hyponatremia. A weight decrease of 1.5 kg corresponds to a fluid loss of approximately 1.5 liters. This demonstrates that the fluid restriction is effective in promoting the excretion of excess water, which is a desired outcome."
            },
            {
                "id": "row_04",
                "rationale": "This finding indicates the client's condition is **Unchanged**. Intense thirst is an expected, albeit distressing, side effect of therapeutic fluid restriction and rising serum osmolality. It does not signify that the underlying SIADH is worsening; rather, it is a consequence of the treatment. The condition is not worsening, but this symptom is a persistent, anticipated challenge."
            },
            {
                "id": "row_05",
                "rationale": "This finding indicates the client's condition is **Worsening**. Erythema and swelling at the IV site suggest a complication such as phlebitis or infiltration. Hypertonic saline (3% NaCl) is a vesicant and can cause significant tissue damage if it infiltrates. This represents a new, adverse event that requires immediate nursing intervention, thus representing a worsening of the client's overall clinical situation."
            },
            {
                "id": "row_06",
                "rationale": "This finding indicates the client's condition is **Improving**. The client's fluid intake is restricted to 1000 mL/day. A urine output of 1400 mL indicates a negative fluid balance of 400 mL, meaning the client is excreting more fluid than they are taking in. This is a sign that the body is effectively eliminating excess free water, a key goal in SIADH management."
            }
        ]
    },
    "references": [
        {
            "source": "Lewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 12th Edition",
            "chapter": "Chapter 47: Endocrine Problems"
        },
        {
            "source": "Ignatavicius, D. D., Workman, M. L., Rebar, C. R., & Heimgartner, N. M. (2021). Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care (10th ed.).",
            "chapter": "Chapter 61: Care of Patients with Pituitary and Adrenal Gland Problems"
        }
    ]
}